Comparing different non-invasive brain stimulation interventions for bipolar depression treatment: A network meta-analysis of randomized controlled trials

Non-invasive brain stimulation (NIBS) is a promising treatment for bipolar depression. We systematically searched for randomized controlled trials on NIBS for treating bipolar depression (INPLASY No: 202340019). Eighteen articles (N = 617) were eligible for network meta-analysis. Effect sizes were r...

Full description

Saved in:
Bibliographic Details
Published in:Neuroscience and biobehavioral reviews 2024-01, Vol.156, p.105483-105483, Article 105483
Main Authors: Hsu, Chih-Wei, Chou, Po-Han, Brunoni, Andre R, Hung, Kuo-Chuan, Tseng, Ping-Tao, Liang, Chih-Sung, Carvalho, Andre F, Vieta, Eduard, Tu, Yu-Kang, Lin, Pao-Yen, Chu, Che-Sheng, Hsu, Tien-Wei, Chen, Yang-Chieh Brian, Li, Cheng-Ta
Format: Article
Language:English
Subjects:
Bipolar Disorder - etiology
Bipolar Disorder - therapy
Brain - physiology
Humans
Network Meta-Analysis
Randomized Controlled Trials as Topic
Transcranial Direct Current Stimulation
Transcranial Magnetic Stimulation
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Non-invasive brain stimulation (NIBS) is a promising treatment for bipolar depression. We systematically searched for randomized controlled trials on NIBS for treating bipolar depression (INPLASY No: 202340019). Eighteen articles (N = 617) were eligible for network meta-analysis. Effect sizes were reported as standardized mean differences (SMDs) or odds ratios (ORs) with 95% confidence intervals (CIs). Anodal transcranial direct current stimulation over F3 plus cathodal transcranial direct current stimulation over F4 (a-tDCS-F3 +c-tDCS-F4; SMD = -1.18, 95%CIs = -1.66 to -0.69, N = 77), high-definition tDCS over F3 (HD-tDCS-F3; -1.17, -2.00 to -0.35, 25), high frequency deep transcranial magnetic stimulation (HF-dTMS; -0.81, -1.62 to -0.001, 25), and high frequency repetitive TMS over F3 plus low frequency repetitive TMS over F4 (HF-rTMS-F3 +LF-rTMS-F4; -0.77, -1.43 to -0.11, 38) significantly improved depressive symptoms compared to sham controls. Only a-tDCS-F3 +c-tDCS-F4 (OR = 4.53, 95%CIs = 1.51-13.65) and HF-rTMS-F3 +LF-rTMS-F4 (4.69, 1.02-21.56) showed higher response rates. No active NIBS interventions exhibited significant differences in dropout or side effect rates, compared with sham controls.
ISSN:0149-7634
1873-7528
DOI:10.1016/j.neubiorev.2023.105483